Creativity and curiosity have always been central to the work of Joshua Moreau, Ph.D., an immunologist whose work at Oregon Health & Science University sits at the intersection of harnessing the immune system; delving into […]
Researchers at National Taiwan University have developed a liver-directed IL-10 gene therapy that strengthens cancer-fighting immune cells and suppresses liver tumors in mice. The treatment also generated long-lasting immune memory cells that remained in the […]
A new study led by NYU Langone Health researchers has found that cancer cells are better able to resist treatments when they have an abnormal number of chromosomes, the DNA strands wound up in bundles […]
Hundreds of thousands of people diagnosed with cancer are still alive today but were never genetically tested, either because testing was not available or was not routinely offered at the time of their diagnosis. These […]
A new University of Kentucky Markey Cancer Center study published in JAMA Internal Medicine found that lung cancer screening rates among eligible U.S. adults have improved in recent years, but fewer than one in four […]
Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it is properly activated. In many patients, however, this response is too weak or too […]
Since a landmark 2009 study, researchers have known that a common gut bacterium, Bacteroides fragilis, drives colon tumor formation, potentially leading to colorectal cancer, by secreting a toxin that damages the lining of the colon. […]
Developed at Aalto University over several years, a new ultrasonic needle for tumor diagnostics has been trialed in collaboration with Helsinki University Hospital (HUS). According to the resulting peer-reviewed study, salivary gland tumors could be […]
The targeted RAS inhibitor daraxonrasib was found to be safe and showed signs of efficacy in patients with previously treated RAS-mutant metastatic pancreatic cancer, according to a Phase I/II first-in-human trial led by Dana-Farber Cancer […]
Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have identified a promising new strategy to overcome resistance to immunotherapy in colorectal cancer, one of the leading […]
© 2025 SimplyWell.ca